Equity · Healthcare
SGRY
NASDAQSurgery Partners, Inc.
$16
−5.88% vs prior close
Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SGRY to draw a line in its place.
Market cap
$2.1B
52-week range
$11.49 – $23.81
Avg volume
296.5K
as of Jul 17, 2026
SGRY insider trades
Open-market buys
1
Open-market sells
0
Net bought
$305K
Non-trade filings
0
Date
Insider
Type
Shares
Value
18 Aug 2026
DeLuca Teresa
Director
Buy
21,250
$305K
SGRY reported financials
SEC EDGARSGRY reported revenue of $3.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$77.9M.
Figure
Reported
Period
Revenue
$3.3B
31 Dec 2025
fiscal year
Net income
−$77.9M
31 Dec 2025
fiscal year
Diluted EPS
−$0.61
31 Dec 2025
fiscal year
Total assets
$8.0B
30 Jun 2026
at period end
Total equity
$1.7B
30 Jun 2026
at period end
SGRY earnings
Date
Period
EPS
Revenue
30 Jun 2026
Q2 2026
−$0.12
—
31 Mar 2026
Q1 2026
−$0.28
—
31 Dec 2025
FY 2025
−$0.61
—
30 Sep 2025
Q3 2025
−$0.18
—
30 Jun 2025
Q2 2025
−$0.02
—
31 Mar 2025
Q1 2025
−$0.30
—
31 Dec 2024
FY 2024
−$1.33
—
30 Sep 2024
Q3 2024
−$0.25
—
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
SGRY institutional holders
SEC EDGAR8 of the 45 institutional funds we track reported a SGRY position for the quarter ended 30 Jun 2026 — a combined $39.3M; the latest of those filings landed 02 Sep 2026.
Fund
Action
Shares
Value
SGRY fails-to-deliver
SECOn 21 Sep 2026, 50 shares of SGRY failed to deliver (about $663).
Settlement date
Shares failed
Notional
% of shares out
21 Sep 2026
50
$663
<0.001%
16 Sep 2026
80
$1K
<0.001%
11 Sep 2026
55,678
$786K
0.043%
08 Sep 2026
16
$228
<0.001%
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARValuation computed from SEC EDGAR filings